Rocket Lab reports Q2 2026 results Monday, August 10, after the close, and options traders are pricing in a roughly 17% swing, well above the stock’s own 10.4% average post-earnings move over the past four quarters. That gap matters more than the usual pre-earnings setup: RKLB is carrying volatility left over from an $8 billion acquisition announcement, not just ordinary earnings uncertainty.
Key Takeaways
- Rocket Lab (RKLB) reports Q2 2026 results Monday, August 10, 2026, after market close. Consensus estimates: revenue near $231.6 million (up about 60% year over year), a per-share loss around $0.06, within the company’s own guided range of $225 million to $240 million.
- The options market is pricing an implied move near 17%, above RKLB’s trailing four-quarter average absolute move of 10.4%, per pre-earnings volatility data from TipRanks.
- The stock closed at $75.67 on August 6, roughly half its May 27 all-time high of $150.23, after a slide to the high $50s in late July driven largely by investor skepticism about Rocket Lab’s proposed $8 billion acquisition of Iridium Communications, not by the company’s underlying launch or satellite business.
- Because a live acquisition is layered on top of ordinary earnings uncertainty, this setup is a useful case study in how a single corporate-action headline can reprice implied volatility independent of the print itself.
- Every example below is hypothetical and illustrative only. Nothing here is a recommendation to buy, sell, or hold RKLB or any option on it.
What happened to RKLB since May
Rocket Lab hit an intraday all-time high of $151 on May 27, 2026 (closing at $150.23), riding a run of Space Force contract wins and a successful Synspective satellite launch. That high didn’t last. On June 29, Rocket Lab announced a definitive agreement to acquire Iridium Communications in a cash-and-stock deal valuing Iridium at approximately $8 billion, with Rocket Lab lining up a $3.6 billion bridge loan from Deutsche Bank and Wells Fargo to cover the cash portion. Iridium holders are set to receive $54 per share, and the deal targets a close in mid-2027, pending shareholder and regulatory approval.
The initial market reaction was positive. RKLB jumped into the mid-teens percentage-wise on announcement day, on the logic that combining launch, satellite manufacturing, and now a global communications constellation makes Rocket Lab a more vertically integrated space company. That reaction faded over the following weeks as investors weighed the dilution from a stock-and-cash deal this large against a two-year-plus integration timeline, and the stock slid to a low near $58 to $59 by late July. It has since recovered a meaningful portion of that drawdown, closing at $75.67 on August 6, but remains roughly 50% below its May peak.
That round trip, not the earnings print by itself, is the real story behind Monday’s elevated implied move. The market isn’t just asking whether Rocket Lab beat estimates. It’s still digesting whether the Iridium deal is value-accretive or a distraction, and management’s commentary on the call is likely to move the stock as much as the numbers themselves.
What the options market is pricing for August 10
Wall Street’s consensus heading into the print sits near $231.6 million in revenue, up about 60% year over year, comfortably inside Rocket Lab’s own guided range of $225 million to $240 million. The consensus per-share figure is a loss of roughly $0.06, reflecting a company still investing heavily in Neutron rocket development and satellite manufacturing capacity ahead of sustained profitability.
The options-implied move, the amount the market expects the stock to move in either direction by expiration, sits near 17% according to pre-earnings volatility roundups. That’s meaningfully above RKLB’s own trailing four-quarter average of 10.4%, and it’s a useful reminder that implied volatility isn’t purely a function of how unpredictable a company’s quarterly numbers are. It also prices in event risk that has nothing to do with the quarter just ended: ongoing uncertainty about Iridium deal terms, financing, and integration.
How to read an expected move like this one
The standard way to estimate an expected move is to take the price of the at-the-money straddle (the ATM call plus the ATM put, both expiring in the nearest weekly cycle after earnings) and divide it by the stock price. A hypothetical illustration: if RKLB is trading at $76 and the nearest weekly ATM straddle is priced around $13, that straddle price divided by the stock price works out to roughly 17%, consistent with the implied move being reported. This is illustrative math only. Anyone actually trading this event should pull the live straddle price the morning of, or the afternoon before, the print, since it moves constantly as the stock and overall market volatility shift.
A strategy framework for a deal-overhang, high-IV name
None of what follows is a recommendation. It’s a framework for thinking about position sizing and structure when a stock is carrying both ordinary earnings risk and deal-related overhang risk at the same time.
- Defined-risk over undefined-risk. A name pricing a 17% move on a $76 stock is pricing roughly $13 of straddle premium. A trader selling premium here without a defined-risk structure, an iron condor or a credit spread rather than a naked short strangle, is accepting a wide range of possible outcomes, including a gap well beyond the priced-in move if the earnings call includes new Iridium deal terms or a financing update.
- Size for the worse of the two stories. A hypothetical trader might size a position as if either the earnings miss or a negative Iridium development could hit on the same day, since both are live possibilities here, rather than sizing for a single, ordinary earnings surprise.
- Watch for IV crush either way. If the print and the call pass without new deal news, implied volatility on RKLB options is likely to compress sharply once the event risk clears, the standard post-earnings pattern. A hypothetical long-premium position, a straddle or strangle bought ahead of the print, needs the actual move to exceed the priced-in 17% just to offset that IV collapse.
This setup is not for a trader who wants a clean, single-variable earnings bet. Anyone uncomfortable holding a position through both quarterly uncertainty and open-ended M&A-integration questions on the same call is better served waiting for the dust to settle, or trading a name whose earnings aren’t also mid-acquisition.
Choosing where to place the trade
A multi-leg structure like an iron condor involves opening and closing four separate contracts, so per-contract commissions compound quickly across brokers. Here’s how the major options-friendly brokers compare on a standard equity options order, verified as of 2026-08-06.
| Broker | Stock commission | Options, per contract (open) | Options, per contract (close) | Notes |
|---|---|---|---|---|
| Charles Schwab / thinkorswim | $0 | $0.65 | $0.65 | Full-featured thinkorswim platform, strong for chain analysis and probability tools. |
| tastytrade | $0 | $1.00 | $0.00 | Options-first platform; closing trades cost nothing, capped at $10 per leg on entry. |
| Interactive Brokers (IBKR Pro) | $0 | $0.65 | $0.65 | Rate applies at 10,000 contracts per month or fewer; falls at higher volume tiers. |
| Webull | $0 | $0.00 | $0.00 | No per-contract fee on single-stock options like RKLB (index options and very high order volume carry separate surcharges). |
For a four-leg structure like an iron condor around an event like this, that per-contract difference adds up across the open and the close. For options-focused execution with real-time Greeks and probability-of-touch tools built for exactly this kind of earnings-volatility setup, tastytrade is worth a look, particularly given the $0 closing cost on a strategy that’s designed to be closed early if it moves against you.
What to listen for on the call beyond the headline number
The revenue and EPS lines matter, but three things are likely to move RKLB more than the quarter itself:
- Neutron development updates. Rocket Lab’s medium-lift Neutron rocket is the company’s path to competing for larger national-security and commercial launch contracts. Any timeline change here, in either direction, tends to move the stock independent of the current quarter’s numbers.
- Iridium integration commentary. Specifics on financing terms, regulatory timeline, or expected synergies (or the lack of new detail) will likely do more to move the stock than the earnings beat or miss itself, since the deal is still the dominant open question for the stock.
- Space Systems segment growth. Rocket Lab’s satellite manufacturing and components business has been growing faster than its launch business in recent quarters; commentary on backlog and margins here speaks to the diversification thesis independent of the Iridium deal.
Bottom Line
RKLB’s elevated implied move into Monday’s print reflects deal uncertainty stacked on top of ordinary earnings risk, not just an unusually unpredictable quarter. Anyone approaching this event should treat it as two overlapping stories, the Q2 numbers and the Iridium integration, and size and structure accordingly using defined risk. Pull the live straddle price and current consensus figures right before you act, since both shift constantly into an event like this.
FAQ
Q: When exactly does Rocket Lab report Q2 2026 earnings?
A: Monday, August 10, 2026, after the market close, per the company’s own investor relations announcement.
Q: What is RKLB’s expected move for this earnings report?
A: Options pricing ahead of the print implies a move near 17% in either direction, above the stock’s own 10.4% average absolute move over the last four quarters. This figure moves constantly and should be re-checked immediately before any decision using the live at-the-money straddle price.
Q: Why is Rocket Lab’s implied volatility so much higher than its historical average?
A: Largely because of the pending $8 billion Iridium acquisition announced June 29, 2026. The stock has round-tripped from a $150.23 all-time high in late May to a low near $58 to $59 in late July and back to $75.67 by early August, driven mostly by shifting investor sentiment on deal terms and dilution, not by changes in Rocket Lab’s underlying launch or satellite business.
Q: What happens to RKLB options if the Iridium deal falls through?
A: If a pending acquisition is terminated, the target’s stock, Iridium in this case, typically falls back toward pre-announcement levels. For the acquirer, Rocket Lab, a broken deal would likely remove the associated financing and dilution overhang, which could cut both ways for the stock depending on how the market weighs the lost strategic rationale against reduced near-term risk. Standard options contracts on RKLB itself are not directly adjusted by the Iridium deal’s outcome, since RKLB is the acquirer, not the target.
Q: Is selling premium into this print a good idea?
A: That depends entirely on individual risk tolerance and account size, and this article isn’t a recommendation either way. What’s worth understanding is that this setup carries two sources of uncertainty stacked together, earnings and deal-integration risk, which argues for defined-risk structures and conservative sizing over an undefined-risk short strangle, regardless of how attractive the premium looks.
Keep learning: for another newly volatile space-sector name that just reported its own first quarter as a changed company, see our SpaceX (SPCX) Q2 2026 earnings recap.